DANBURY, Conn., Sept. 17 /PRNewswire-FirstCall/ — Biodel Inc.
BIOD) announced today the appointment of Arthur Urciuoli to the
company’s board of directors. Mr. Urciuoli is chairman of
ArcherGroup, a private investment and consulting services firm, and
was recently elected to the board of the newly-formed Kroll Bond
Rating Agency. He is a retired chairman of Merrill Lynch
International and former director of Kroll, Inc. He spent 30
years at Merrill Lynch & Company where he held a variety of
senior leadership positions, including chairman and chief executive
of Merrill Lynch Business Financial Services and director of
Merrill Lynch Private Banking, and was a syndicated columnist and
frequent guest speaker on investing and business management.
Biodel’s president and chief executive officer, Dr. Errol De
Souza, stated: “Archie Urciuoli has an outstanding record of
achievement in international finance and corporate governance.
We believe his experience in financing public companies and
developing successful business strategies will be extremely
valuable as we work to build our product pipeline and company.
We welcome his counsel and contributions to our future
Mr. Urciuoli stated: “I am honored to join the Biodel
board at this important time in the company’s history. With
one product candidate under review for U.S. marketing approval and
other drugs advancing into clinical development, Biodel faces
exciting opportunities to improve the lives of people with diabetes
and become a successful pharmaceutical company. I look
forward to working with the rest of the board and a very talented
management team to help realize the company’s full potential.”
Mr. Urciuoli was a captain in the U.S. Marine Corps and is a
graduate of St. Lawrence University, Georgetown University Law
School and the